Pulmonary Hypertension (PH) Terminated Phase 4 Trials for Ambrisentan (DB06403)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00840463Safety and Efficacy Trial to Treat Diastolic Heart Failure Using AmbrisentanDiagnostic